Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Johnson & Johnson (JNJ)

132.5   -2.21 (-1.64%) 07-16 16:02
Open: 132.93 Pre. Close: 134.71
High: 133.82 Low: 131.7701
Volume: 9,052,136 Market Cap: 351795M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 136.424 - 137.248 137.248 - 138.037
Low: 132.491 - 133.466 133.466 - 134.4
Close: 133.228 - 134.652 134.652 - 136.017

Technical analysis

as of: 2019-07-16 3:21:59 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 163.44     One year: 169.34
Support: Support1: 131.77    Support2: 109.63
Resistance: Resistance1: 139.93    Resistance2: 144.98
Pivot: 139.55
Moving Average: MA(5): 136.55     MA(20): 140.07
MA(100): 138.33     MA(250): 136.78
MACD: MACD(12,26): -0.87     Signal(9): 0.17
Stochastic oscillator: %K(14,3): 13.12     %D(3): 20.08
RSI: RSI(14): 31.55
52-week: High: 148.99  Low: 121.00  Change(%): 2.6
Average Vol(K): 3-Month: 697852  10-Days: 667380

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
JNJ has closed below the lower band by 7.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 78.8% wider than normal. The large width of the bands suggest high volatility as compared to JNJ's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Tue, 16 Jul 2019 00:13:59 Z
AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes

Tue, 16 Jul 2019 00:07:31 Z
J&J Submits BLA for Subcutaneous Formulation of Darzalex

Mon, 15 Jul 2019 22:07:45 Z
Stocks End Choppy Session at New Highs

Mon, 15 Jul 2019 20:16:28 Z
Pre-Market Earnings Report for July 16, 2019 : JPM, JNJ, WFC, GS, PLD, CP, FRC, DPZ, CBSH, SNV, FHN, MBWM

Mon, 15 Jul 2019 19:06:50 Z
Daily Dividend Report: JNJ, VMC, AGCO, GT, CBT

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2660.00
Shares Float (M) 2650.00
% Held by Insiders 0.07
% Held by Institutions 69.23
Shares Short (K) 13390
Shares Short P. Month (K)

Stock Financials

EPS 5.400
EPS Est. Current Year 7.280
EPS Est. Next Year 7.850
EPS Est. Next Quarter 1.990
Forward EPS 8.583
Book Value (p.s.) 22.200
PEG Ratio 2.51
Profit Margin 17.99
Operating Margin 25.85
Return on Assets (ttm) 8.6
Return on Equity (ttm) 24.0
Qtrly Rev. Growth 0.1
Gross Profit (p.s.) 20.523
Sales Per Share
EBITDA (p.s.) 10.538
Qtrly Earnings Growth -14.20
Operating Cash Flow (M) 22140.00
Levered Free Cash Flow (M) 20580.00

Stock Valuations

P/E 24.52
P/E Growth Ratio -0.02
P/BV 5.96
P/S 11551676416.00
P/CF 15.91

Dividends & Splits

Dividend 3.600
Dividend Yield 0.03
Dividend Pay Date 2019-06-11
Ex-Dividend Date 2019-05-24
Forward Dividend 3.800
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.